MarketCap
Facebook
X
TelegramQuarterly report 2024-Q3
added 11-12-2024
Natera Total Inventories 2011-2026 | NTRA
Annual Total Inventories Natera
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 35.4 M | 26.9 M | 20 M | 12.4 M | 13.6 M | 9 M | 6.41 M | 8.09 M | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 35.4 M | 6.41 M | 16.5 M |
Quarterly Total Inventories Natera
| 2024-Q3 | 2023-Q4 | 2023-Q3 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 48.7 M | 40.8 M | - | - | - | - | 25 M | 26.9 M | 28 M | 28.4 M | 23.7 M | 20 M | 20 M | 20 M | 20 M | 12.4 M | 12.4 M | 12.4 M | 12.4 M | 13.6 M | 13.6 M | 13.6 M | 13.6 M | 9 M | 9 M | 9 M | 9 M | 6.41 M | 6.41 M | 6.41 M | 6.41 M | 8.09 M | 8.09 M | 8.09 M | 8.09 M | 11.5 M | 11.5 M | 11.5 M | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 48.7 M | 6.41 M | 15.7 M |
Total Inventories of other stocks in the Diagnostics research industry
| Issuer | Total Inventories | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Co-Diagnostics
CODX
|
992 K | $ 1.32 | -19.18 % | $ 1.76 M |  USA |
 |
Agilent Technologies
A
|
830 M | $ 112.44 | -0.71 % | $ 34.2 B | USA |
 |
Castle Biosciences
CSTL
|
10.3 M | $ 19.2 | 1.69 % | $ 557 M | USA |
 |
Aspira Women's Health
AWH
|
256 K | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
5.19 M | - | -61.36 % | $ 2.46 M | USA |
 |
Biocept
BIOC
|
757 K | - | -13.05 % | $ 7.29 M | USA |
 |
Illumina
ILMN
|
547 M | $ 140.85 | -1.67 % | $ 22.4 B | USA |
 |
Interpace Biosciences
IDXG
|
1.11 M | $ 1.8 | - | $ 7.96 M | USA |
 |
CareDx, Inc
CDNA
|
26.7 M | $ 19.88 | -2.98 % | $ 1.06 B | USA |
 |
Chembio Diagnostics
CEMI
|
7.72 M | - | 0.22 % | $ 16.8 M | USA |
 |
HTG Molecular Diagnostics
HTGM
|
909 K | - | -20.0 % | $ 1.06 M | USA |
 |
Lantheus Holdings
LNTH
|
64.7 M | $ 94.55 | -2.2 % | $ 6.38 B | USA |
 |
Mettler-Toledo International
MTD
|
387 M | $ 1 051.07 | 0.88 % | $ 21.7 B |  Schweiz |
 |
Global Cord Blood Corporation
CO
|
45.9 M | - | - | $ 399 M |  China |
 |
Myriad Genetics
MYGN
|
30.6 M | $ 3.65 | 0.69 % | $ 338 M | USA |
 |
NeoGenomics
NEO
|
28.6 M | $ 8.32 | -0.54 % | $ 1.07 B | USA |
 |
DermTech
DMTK
|
1 M | - | -11.32 % | $ 2.94 M | USA |
 |
Charles River Laboratories International
CRL
|
299 M | $ 155.97 | -1.98 % | $ 7.73 B | USA |
 |
Enzo Biochem
ENZ
|
6.83 M | - | -8.98 % | $ 14.8 K | USA |
 |
Exact Sciences Corporation
EXAS
|
166 M | - | - | $ 19.8 B | USA |
 |
Guardant Health
GH
|
85.9 M | $ 93.95 | -4.77 % | $ 11.8 B | USA |
 |
Senseonics Holdings
SENS
|
6.7 M | $ 5.71 | -1.89 % | $ 238 M | USA |
 |
Heska Corporation
HSKA
|
60 M | - | - | $ 1.31 B | USA |
 |
ICON Public Limited Company
ICLR
|
2.3 M | $ 118.48 | 1.19 % | $ 9.77 B |  Irlanda |
 |
Soleno Therapeutics
SLNO
|
15 M | $ 52.98 | -0.02 % | $ 2.69 B | USA |
 |
QIAGEN N.V.
QGEN
|
302 M | - | - | $ 10.6 B |  Niderland |
 |
Biomerica
BMRA
|
1.49 M | $ 2.36 | -2.07 % | $ 5.42 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
535 M | $ 252.76 | -0.5 % | $ 21 B | USA |
 |
Thermo Fisher Scientific
TMO
|
5.42 B | - | - | $ 167 B | USA |
 |
Motus GI Holdings
MOTS
|
496 K | - | -34.28 % | $ 263 K |  Israel |
 |
Twist Bioscience Corporation
TWST
|
28.3 M | $ 48.6 | -8.22 % | $ 2.91 B | USA |
 |
Neogen Corporation
NEOG
|
191 M | $ 8.32 | -1.25 % | $ 1.8 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
189 M | $ 187.2 | -0.39 % | $ 20.8 B | USA |
 |
Invitae Corporation
NVTA
|
30.4 M | - | - | $ 21.2 M | USA |